RTN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.316400E-01
Normal-vs-Stage2
5.492800E-01
Normal-vs-Stage3
9.570800E-01
Normal-vs-Stage4
6.705400E-01
Stage1-vs-Stage2
7.090000E-01
Stage1-vs-Stage3
6.720000E-01
Stage1-vs-Stage4
8.515400E-01
Stage2-vs-Stage3
4.411800E-01
Stage2-vs-Stage4
9.022600E-01
Stage3-vs-Stage4
6.238600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.369000E-01
Normal-vs-AfricanAmerican
5.593000E-01
Normal-vs-Asian
8.283400E-01
Caucasian-vs-AfricanAmerican
6.647000E-01
Caucasian-vs-Asian
1.099240E-01
AfricanAmerican-vs-Asian
2.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.960000E-01
Normal-vs-Female
5.074200E-01
Male-vs-Female
8.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.986800E-01
Normal-vs-Age(41-60Yrs)
1.688190E-01
Normal-vs-Age(61-80Yrs)
7.852600E-01
Normal-vs-Age(81-100Yrs)
6.909000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.654620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.832400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.802400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.405600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.418300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.598000E-01
Normal-vs-Daily Drinker
9.822600E-01
Normal-vs-Weekly Drinker
9.884400E-01
Normal-vs-Occasional Drinker
3.396400E-01
Normal-vs-Social Drinker
5.380600E-01
Non Drinker-vs-Daily Drinker
7.520800E-01
Non Drinker-vs-Weekly Drinker
7.489800E-01
Non Drinker-vs-Occasional Drinker
8.590500E-02
Non Drinker-vs-Social Drinker
4.130200E-01
Daily Drinker-vs-Weekly Drinker
9.840200E-01
Daily Drinker-vs-Occasional Drinker
7.083800E-02
Daily Drinker-vs-Social Drinker
3.111800E-01
Weekly Drinker-vs-Occasional Drinker
7.577700E-02
Weekly Drinker-vs-Social Drinker
2.838600E-01
Occasional Drinker-vs-Social Drinker
4.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.739800E-02
Normal-vs-Grade 2
3.116600E-03
Normal-vs-Grade 3
1.464380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.091400E-01
Grade 1-vs-Grade 3
7.320100E-02
Grade 1-vs-Grade 4
5.739800E-02
Grade 2-vs-Grade 3
4.036600E-01
Grade 2-vs-Grade 4
3.116600E-03
Grade 3-vs-Grade 4
1.464380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.805200E-01
Normal-vs-NonDiabetic
5.882400E-01
Diabetic-vs-NonDiabetic
8.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.790800E-01
Normal-vs-NoPancreatitis
6.259800E-01
Pancreatitis-vs-NoPancreatitis
7.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.236800E-01
Normal-vs-N1
5.209600E-01
N0-vs-N1
5.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.432600E-01
Normal-vs-TP53-NonMutant
4.614000E-01
TP53-Mutant-vs-TP53-NonMutant
2.723300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
